A Phase IB/II Multi-Cohort Study of Targeted Agents with Atezolizumab for Patients with Recurrent or Persistent Endometrial Cancer
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
Alliance Foundation Trials, LLC
Start Date
September 1, 2021
End Date
August 31, 2025
Administered By
Medicine, Medical Oncology
Awarded By
Alliance Foundation Trials, LLC
Start Date
September 1, 2021
End Date
August 31, 2025